Lagevrio
Payments companies reported to CMS as associated with Lagevrio. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Lagevrio, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Lagevrio
These are the largest totals companies reported as associated with Lagevrio. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Anthony Scialli | Washington, DC | Gynecology | $2,441.25 |
| Etsegenet Ayele | Los Alamitos, CA | Internal Medicine | $2,373.65 |
| Bob Hutchins | Jackson, MS | Internal Medicine | $2,295.43 |
| Holly Berndt-Hilu | Grosse Pointe Woods, MI | Clinical Nurse Specialist | $1,776.42 |
| Louis Saravolatz | Grosse Pointe Woods, MI | Infectious Disease | $1,739.47 |
| Kevin Oei | Downey, CA | Family Medicine | $1,724.69 |
| Nadia Cameron | Atlanta, GA | Family Medicine | $1,557.03 |
| Denise Johnson | Teaneck, NJ | Adult Health (Nurse Practitioner) | $1,514.74 |
| Eduardo Miralles Alonso | San Juan, PR | General Practice | $1,506.11 |
| Ginger Patel | Houston, TX | Family | $1,457.10 |
Prescribed Lagevrio?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.